Evidence map›Paper›PMID 31552885›Full record

ArticleNeural regeneration research2020

Genetic targeting of astrocytes to combat neurodegenerative disease.

Rachel Kery, Allen P F Chen, Gregory W Kirschen

Abstract read
In one paragraph

Article in Neural regeneration research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Astrocyte involvement in metabolic regulation and disease.Trends in endocrinology and metabolism: TEM · 2025
    Review
  9. Review
  10. Article
  11. Review
  12. Promoted CD4Journal of neuroinflammation · 2022
    Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Glia Crosstalk in Neuroinflammatory Diseases.Frontiers in cellular neuroscience · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rachel KeryMedical Scientist Training Program (MSTP), Stony Brook Medicine; Department of Neurobiology & Behavior, Stony Brook University, Stony Brook, NY, USA.
Allen P F ChenMedical Scientist Training Program (MSTP), Stony Brook Medicine; Department of Neurobiology & Behavior, Stony Brook University, Stony Brook, NY, USA.
Gregory W KirschenMedical Scientist Training Program (MSTP), Stony Brook Medicine, Stony Brook, NY, USA.

Funding

Dopaminergic modulation in auditory decision-makingF30DC018214 · NIDCD · STATE UNIVERSITY NEW YORK STONY BROOK · PI CHEN, ALLEN · 2019 to 2023
$213k
The role of adult-born dentate granule cells in influencing C3 neuronal activityF30MH116650 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI KERY, RACHEL ELIZABETH · 2018 to 2021
$178k
Studying enriched environment-induced hippocampal neurogenesis using virtual reality exposureF30MH110103 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI KIRSCHEN, GREGORY WOHL · 2016 to 2018
$103k
NIDCD NIH HHS F30 DC018214NIMH NIH HHS F30 MH110103NIMH NIH HHS F30 MH116650
6 · The paper itself

Abstract

Astrocytes, glial cells that interact extensively with neurons and other support cells throughout the central nervous system, have recently come under the spotlight for their potential contribution to, or potential regenerative role in a host of neurodegenerative disorders. It is becoming increasingly clear that astrocytes, in concert with microglial cells, activate intrinsic immunological pathways in the setting of neurodegenerative injury, although the direct and indirect consequences of such activation are still largely unknown. We review the current literature on the astrocyte's role in several neurodegenerative diseases, as well as highlighting recent advances in genetic manipulation of astrocytes that may prove critical to modulating their response to neurological injury, potentially combatting neurodegenerative damage.

Indexed as

Alzheimer’s diseaseamyotrophic lateral sclerosisgliaimmune systeminflammationParkinson’s diseasereactive astrocyteregeneration

Identifiers

PMID31552885
PMCPMC6905329

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.